# Study of Apixaban for the Prevention of Thrombosis-related Events in Patients With Acute Medical Illness

> **NCT00457002** · PHASE3 · COMPLETED · sponsor: **Bristol-Myers Squibb** · enrollment: 6758 (actual)

## Conditions studied

- Venous Thrombosis
- Pulmonary Embolism

## Interventions

- **DRUG:** Apixaban
- **DRUG:** Enoxaparin

## Key facts

- **NCT ID:** NCT00457002
- **Lead sponsor:** Bristol-Myers Squibb
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-06
- **Primary completion:** 2011-05
- **Final completion:** 2011-05
- **Target enrollment:** 6758 (ACTUAL)
- **Last updated:** 2015-12-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00457002

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00457002, "Study of Apixaban for the Prevention of Thrombosis-related Events in Patients With Acute Medical Illness". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT00457002. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*